KRYS – Krystal Biotech, Inc.
Krystal Biotech, Inc.KRYS
$166.01Name : Krystal Biotech, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,797,423,104.00
EPSttm : 3.01
Krystal Biotech, Inc.
$166.01
3.09%$5.29Float Short %
10.97
Margin Of Safety %
47
Put/Call OI Ratio
0.47
EPS Next Q Diff
0.03
EPS Last/This Y
4.46
EPS This/Next Y
3.19
Price
166.15
Target Price
214.8
Analyst Recom
1.18
Performance Q
4.85
Relative Volume
1.86
Beta
0.77
Ticker: KRYS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-10 | KRYS | 184.11 | 0.54 | 0.71 | 4394 |
| 2025-03-11 | KRYS | 184.77 | 0.55 | 0.32 | 4520 |
| 2025-03-12 | KRYS | 178.41 | 0.55 | 110.00 | 4548 |
| 2025-03-13 | KRYS | 177.52 | 0.62 | 0.00 | 4765 |
| 2025-03-14 | KRYS | 179.42 | 0.62 | 3.00 | 4775 |
| 2025-03-17 | KRYS | 186.83 | 0.62 | 2.50 | 4775 |
| 2025-03-18 | KRYS | 188.49 | 0.64 | 0.00 | 4841 |
| 2025-03-19 | KRYS | 188.9 | 0.41 | 0.04 | 6653 |
| 2025-03-20 | KRYS | 188.88 | 0.36 | 0.00 | 7519 |
| 2025-03-21 | KRYS | 187.17 | 0.38 | 0.33 | 7919 |
| 2025-03-24 | KRYS | 194.75 | 0.46 | 0.06 | 4467 |
| 2025-03-25 | KRYS | 192.14 | 0.44 | 0.24 | 4577 |
| 2025-03-26 | KRYS | 186.92 | 0.46 | 999.99 | 4527 |
| 2025-03-27 | KRYS | 182.75 | 0.46 | 1.44 | 4537 |
| 2025-03-28 | KRYS | 183.15 | 0.47 | 2.00 | 4571 |
| 2025-03-31 | KRYS | 179.11 | 0.47 | 0.14 | 4581 |
| 2025-04-01 | KRYS | 173.83 | 0.47 | 0.00 | 4585 |
| 2025-04-02 | KRYS | 180.78 | 0.47 | 0.40 | 4592 |
| 2025-04-03 | KRYS | 177.75 | 0.47 | 2.10 | 4592 |
| 2025-04-04 | KRYS | 171.32 | 0.47 | 0.20 | 4588 |
| 2025-04-07 | KRYS | 165.01 | 0.47 | 0.76 | 4590 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-10 | KRYS | 184.05 | 202.8 | 114.5 | 7.58 |
| 2025-03-11 | KRYS | 184.76 | 202.8 | 110.5 | 7.58 |
| 2025-03-12 | KRYS | 178.52 | 202.8 | 101.0 | 7.58 |
| 2025-03-13 | KRYS | 177.37 | 202.8 | 107.8 | 7.58 |
| 2025-03-14 | KRYS | 179.38 | 202.8 | 111.9 | 7.58 |
| 2025-03-17 | KRYS | 186.89 | 202.8 | 119.2 | 7.58 |
| 2025-03-18 | KRYS | 188.50 | 202.8 | 111.3 | 7.58 |
| 2025-03-19 | KRYS | 189.18 | 202.8 | 110.0 | 7.58 |
| 2025-03-20 | KRYS | 188.61 | 202.8 | 108.5 | 7.58 |
| 2025-03-21 | KRYS | 187.17 | 202.8 | 107.4 | 7.58 |
| 2025-03-24 | KRYS | 194.44 | 202.8 | 118.6 | 7.58 |
| 2025-03-25 | KRYS | 192.30 | 202.8 | 106.6 | 7.58 |
| 2025-03-26 | KRYS | 187.10 | 202.8 | 102.8 | 7.58 |
| 2025-03-27 | KRYS | 182.62 | 202.8 | 103.5 | 7.58 |
| 2025-03-28 | KRYS | 183.92 | 202.8 | 110.7 | 7.58 |
| 2025-03-31 | KRYS | 180.30 | 202.8 | 104.5 | 7.58 |
| 2025-04-01 | KRYS | 174.58 | 202.8 | 102.0 | 7.58 |
| 2025-04-02 | KRYS | 181.00 | 202.8 | 118.0 | 7.58 |
| 2025-04-03 | KRYS | 178.13 | 202.8 | 105.4 | 7.58 |
| 2025-04-04 | KRYS | 171.16 | 202.8 | 99.8 | 7.58 |
| 2025-04-07 | KRYS | 166.15 | 202.8 | 102.4 | 7.58 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-10 | KRYS | -4.47 | -0.86 | 13.00 |
| 2025-03-11 | KRYS | -4.47 | -0.86 | 13.00 |
| 2025-03-12 | KRYS | -4.47 | -0.86 | 11.27 |
| 2025-03-13 | KRYS | -4.47 | -0.86 | 11.27 |
| 2025-03-14 | KRYS | -4.48 | -0.86 | 11.26 |
| 2025-03-17 | KRYS | -4.48 | -0.85 | 11.26 |
| 2025-03-18 | KRYS | -4.48 | -0.85 | 11.26 |
| 2025-03-19 | KRYS | -4.58 | -0.85 | 11.22 |
| 2025-03-20 | KRYS | -4.58 | -0.85 | 11.22 |
| 2025-03-21 | KRYS | -4.58 | -0.85 | 11.22 |
| 2025-03-24 | KRYS | -4.58 | -0.81 | 11.22 |
| 2025-03-25 | KRYS | -4.58 | -0.81 | 11.22 |
| 2025-03-26 | KRYS | -4.58 | -0.81 | 10.97 |
| 2025-03-27 | KRYS | -4.58 | -0.81 | 10.97 |
| 2025-03-28 | KRYS | -4.58 | -0.81 | 10.97 |
| 2025-03-31 | KRYS | -4.58 | -0.82 | 10.97 |
| 2025-04-01 | KRYS | -4.58 | -0.82 | 10.97 |
| 2025-04-02 | KRYS | -4.58 | -0.82 | 10.97 |
| 2025-04-03 | KRYS | -4.58 | -0.82 | 10.97 |
| 2025-04-04 | KRYS | -4.58 | -0.82 | 10.97 |
| 2025-04-07 | KRYS | -4.58 | -0.84 | 10.97 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.52
Avg. EPS Est. Current Quarter
1.39
Avg. EPS Est. Next Quarter
1.55
Insider Transactions
-4.58
Institutional Transactions
-0.84
Beta
0.77
Average Sales Estimate Current Quarter
99
Average Sales Estimate Next Quarter
108
Fair Value
243.64
Quality Score
79
Growth Score
44
Sentiment Score
57
Actual DrawDown %
24.3
Max Drawdown 5-Year %
-53.4
Target Price
214.8
P/E
55.56
Forward P/E
15.3
PEG
0.82
P/S
16.46
P/B
5.05
P/Free Cash Flow
40.12
EPS
2.99
Average EPS Est. Cur. Y
7.58
EPS Next Y. (Est.)
10.77
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
30.69
Relative Volume
1.86
Return on Equity vs Sector %
-10.3
Return on Equity vs Industry %
2.6
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
0.83
EBIT Estimation
102.4
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 275
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading